|
BTAF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.551900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.136000E-03 |
| Normal-vs-Stage2 |
9.617500E-02 |
| Normal-vs-Stage3 |
3.583600E-01 |
| Normal-vs-Stage4 |
3.504000E-01 |
| Stage1-vs-Stage2 |
5.924600E-01 |
| Stage1-vs-Stage3 |
1.377990E-03 |
| Stage1-vs-Stage4 |
3.141600E-03 |
| Stage2-vs-Stage3 |
5.110000E-02 |
| Stage2-vs-Stage4 |
5.042100E-02 |
| Stage3-vs-Stage4 |
9.598200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.655200E-03 |
| Normal-vs-AfricanAmerican |
8.919500E-03 |
| Normal-vs-Asian |
8.555200E-01 |
| Caucasian-vs-AfricanAmerican |
2.655800E-01 |
| Caucasian-vs-Asian |
4.529800E-01 |
| AfricanAmerican-vs-Asian |
3.424400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.898460E-03 |
| Normal-vs-Female |
4.664500E-03 |
| Male-vs-Female |
5.713800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.283770E-01 |
| Normal-vs-Extreme_Weight |
1.232150E-01 |
| Normal-vs-Obese |
1.171560E-02 |
| Normal-vs-Extreme_Obese |
6.061600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.098400E-01 |
| Normal_Weight-vs-Obese |
4.475800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.000200E-01 |
| Extreme_Weight-vs-Obese |
3.430800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.860400E-01 |
| Obese-vs-Extreme_Obese |
4.361800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.548200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.192940E-04 |
| Normal-vs-Age(61-80Yrs) |
6.128100E-02 |
| Normal-vs-Age(81-100Yrs) |
8.383600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.530400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.705830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.011430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.950400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.959700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.745200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.55810000004963E-06 |
| Normal-VS-Type2 PRCC |
2.607700E-02 |
| Normal-VS-KIRP CIMP |
3.183800E-01 |
| Normal-VS-Unclassified PRCC |
3.802400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.10280023896325E-10 |
| Type1 PRCC-VS-KIRP CIMP |
7.229600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.335200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.003600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.221400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.660200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.355400E-01 |
| Normal-vs-N1 |
5.095800E-01 |
| Normal-vs-N2 |
9.706000E-01 |
| N0-vs-N1 |
9.980800E-01 |
| N0-vs-N2 |
7.926800E-01 |
| N1-vs-N2 |
7.636400E-01 |
|
|
